Stem cell exosome treatment for congenital myasthenic syndrome
Part of Brain & nervous system, Genetic & congenital clinical trials.
This trial tests a treatment made from stem cell exosomes (tiny particles that may help repair cells) for people with congenital myasthenic syndrome, a muscle-weakening condition. It aims to see if this treatment is safe and could improve symptoms.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have been diagnosed with congenital myasthenic syndrome by a doctor.
- You must be able to give permission to join the trial, or have a parent or guardian who can.
- You must be able to travel to the treatment location.
- You cannot be pregnant at the time of screening.
- You cannot have active cancer at the screening visit.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a special type of stem cell (neuroinduced mesenchymal stem cells) and their exosomes can safely help people with spinocerebellar palsy. It's an early study focusing on safety and possible improvement in symptoms.
This trial tests a new drug made from stem cell exosomes (CB-Exo-A600) to see if it can help people with mild to moderate Alzheimer's disease. It aims to slow down symptoms and improve quality of life.
This trial tests a new treatment using stem cell-derived exosomes (tiny particles that help cells communicate) to heal diabetic foot ulcers. It aims to see if this approach is safe and effective for people with diabetic foot.
This clinical trial is testing a treatment made from stem cell exosomes — tiny particles that help cells communicate — given through an IV to people who have had a recent ischemic stroke caused by a blood clot. The study aims to see if it's safe and can help recovery when given within the first few days after a stroke.
This study tests a new therapy made from donor stem cells that may help repair damaged muscles, bones, tendons, and joints. It is for people whose injuries or degenerative conditions have not healed on their own.
This trial studies whether a treatment made from tiny cell packets (exosomes) can help protect the brain in extremely low birth weight, very premature newborns. It’s meant to test whether the approach is safe and may reduce brain-related harm from prematurity.
Hear when a new Congenital Myasthenic Syndrome trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.